Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With Hemodialysis.
PD+HD
cardiovascular event
combined dialysis
end-stage renal disease (ESRD)
residual kidney function (RKF)
survival
Journal
Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
08
10
2019
revised:
31
12
2019
accepted:
13
01
2020
entrez:
14
4
2020
pubmed:
14
4
2020
medline:
14
4
2020
Statut:
epublish
Résumé
Combination therapy with peritoneal dialysis and hemodialysis (PD+HD) is widely used for PD patients with decreased residual kidney function in Japan; however, hospitalization for this combined dialysis has not been investigated so far. We compared the risk of hospitalization for PD+HD with that for HD. A multicenter, prospective observational study was conducted on 42 PD+HD and 42 HD patients matched for age and diabetic nephropathy. The main outcome measure was the cumulative incidence of hospitalization for any cause assessed with the Kaplan-Meier method. Hospitalization rates (the number of admissions per 100 patient-years) associated with dialysis modality were also calculated. The impact of dialysis modality on time to hospitalization was analyzed using the Cox proportional hazard model. There was no significant difference between groups in terms of age, sex, dialysis vintage, diabetic nephropathy, and comorbidities. The cumulative incidence of hospitalization did not significantly differ between the groups (log-rank test, The risk of hospitalization was not significantly different between PD+HD and HD, although PD+HD patients had a higher risk of dialysis access-related complications than HD patients.
Identifiants
pubmed: 32280842
doi: 10.1016/j.ekir.2020.01.004
pii: S2468-0249(20)30025-5
pmc: PMC7136431
doi:
Types de publication
Journal Article
Langues
eng
Pagination
468-474Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 International Society of Nephrology. Published by Elsevier Inc.
Références
Kidney Int. 2000 Jul;58(1):446-57
pubmed: 10886593
Am J Kidney Dis. 2001 Jul;38(1):85-90
pubmed: 11431186
J Am Soc Nephrol. 2010 Mar;21(3):499-506
pubmed: 20133483
Clin Nephrol. 2010 Sep;74(3):209-16
pubmed: 20860905
Perit Dial Int. 2016 9-10;36(5):481-508
pubmed: 27282851
J Am Soc Nephrol. 2004 Apr;15(4):1061-70
pubmed: 15034110
Clin J Am Soc Nephrol. 2012 Oct;7(10):1598-605
pubmed: 22904124
Ther Apher Dial. 2013 Jun;17(3):247-88
pubmed: 23735142
Kidney Int. 2016 Aug;90(2):262-271
pubmed: 27182000
Perit Dial Int. 2006 Mar-Apr;26(2):150-4
pubmed: 16623416
Semin Nephrol. 2018 Jul;38(4):426-432
pubmed: 30082062
Am J Kidney Dis. 1997 Sep;30(3):334-42
pubmed: 9292560
Ther Apher Dial. 2017 Apr;21(2):180-184
pubmed: 28185405
Am J Kidney Dis. 2016 Aug;68(2):256-265
pubmed: 26867814
Ther Apher Dial. 2004 Feb;8(1):56-61
pubmed: 15128021
Nephrol Dial Transplant. 2012 Sep;27(9):3568-75
pubmed: 22391139
J Am Soc Nephrol. 2000 Jan;11(1):116-25
pubmed: 10616847
J Am Soc Nephrol. 2016 Dec;27(12):3758-3768
pubmed: 27169576
J Am Soc Nephrol. 1999 Feb;10(2):354-65
pubmed: 10215336
J Am Soc Nephrol. 1995 May;5(11):1940-8
pubmed: 7620092
Am J Kidney Dis. 1992 Mar;19(3):246-51
pubmed: 1553969
Perit Dial Int. 2011 Sep-Oct;31(5):598-600
pubmed: 21976476
Perit Dial Int. 2007 Jun;27 Suppl 2:S126-9
pubmed: 17556290
Semin Nephrol. 2018 Jul;38(4):325-335
pubmed: 30082053
J Ren Care. 2007 Oct-Dec;33(4):165-71
pubmed: 18298034
Kidney Int Suppl. 2006 Nov;(103):S127-32
pubmed: 17080104
Perit Dial Int. 1990;10(1):15-9
pubmed: 2085575
Arch Intern Med. 1986 Jun;146(6):1138-43
pubmed: 3718101
Lancet. 1987 Nov 14;2(8568):1105-9
pubmed: 2890018
Kidney Int. 2001 Feb;59(2):754-63
pubmed: 11168959
J Am Soc Nephrol. 2000 Mar;11(3):556-64
pubmed: 10703680
Perit Dial Int. 2020 Jan 17;:896860819894066
pubmed: 32063200
Kidney Int. 2006 May;69(10):1726-32
pubmed: 16612329